| Literature DB >> 29316772 |
Yoshiro Abe1, Keisuke Kashiwagi1, Soushi Ishida1, Kazuhide Mineda1, Yutaro Yamashita1, Ichiro Hashimoto1.
Abstract
BACKGROUND: The free anterolateral thigh (ALT) flap has been widely used for various kinds of reconstructions. However, delayed healing at the donor site occasionally occurs due to wound dehiscence or the partial loss of grafted skin at the donor site. The aim of the present study was to identify reliable predictive factors for delayed healing at the donor site after the harvest of a free ALT flap.Entities:
Keywords: Free tissue flaps; Reconstructive surgical procedures; Risk factors; Wound healing
Year: 2018 PMID: 29316772 PMCID: PMC5784382 DOI: 10.5999/aps.2017.00563
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
The lesions that underwent free anterolateral thigh flap reconstruction and the recipient sites
| Lesion/Recipient site | No. (%) |
|---|---|
| Lesion | |
| Malignant tumor | 34 (65.4) |
| Contracture | 9 (17.3) |
| Refractory ulcer | 7 (13.5) |
| Benign tumor | 2 (3.8) |
| Recipient site | |
| Head and neck | 42 (80.8) |
| Lower limb | 5 (9.6) |
| Upper limb | 4 (7.7) |
| Trunk | 1 (1.9) |
Fig. 1.ALT flap harvest and donor site closure
(A) An intramuscular dissection was performed along the perforator when a perforator traveled through the vastus lateralis muscle. (B) Two segments of the vastus lateralis muscle nourished by the muscular branch from the descending branch of the lateral circumflex femoral artery were incorporated into the ALT skin flap. (C) A split-thickness meshed skin graft with a bolster dressing was applied on the remaining muscles after harvesting the flap. ALT, anterolateral thigh.
Characteristics of the patients who underwent free ALT flap reconstruction
| Characteristic | Delayed healing group (n = 24) | Non-delayed healing group (n = 28) |
|---|---|---|
| Age (yr) | 52.8 ± 15.9 (18–80) | 59.2 ± 13.5 (29–82) |
| Body mass index (kg/m2) | 26.2 ± 3.3 (20.4–34.6) | 22.3 ± 3.4 (16–30.1) |
| Hypertension (%) | 5 (20.8) | 7 (25.0) |
| Hyperlipidemia (%) | 8 (33.3) | 9 (32.1) |
| Diabetes mellitus (%) | 3 (12.5) | 2 (7.1) |
| Smoking (%) | 19 (79.2) | 11 (39.3) |
| Hemoglobin (g/dL) | 13.4 ± 1.8 (10.9–17.2) | 12.3 ± 1.9 (7.4–15.6) |
| Total protein (g/dL) | 6.9 ± 0.6 (5.6–7.7) | 7.0 ± 0.7 (5.6–8.1) |
| Albumin (g/dL) | 3.8 ± 0.4 (2.8–4.6) | 3.7 ± 0.5 (2.6–4.6) |
| Skin flap size (cm2) | 171.2 ± 91.7 (59–425) | 123.3 ± 78.0 (30–368) |
| VLM flap size (cm2) | 32.8 ± 34.7 (0–130) | 21.4 ± 30.9 (0–127) |
| No. of included perforators (%) | ||
| 1 | 10 (41.7) | 15 (53.6) |
| 2 < | 14 (58.3) | 13 (46.4) |
| Perforator type (%) | ||
| Musculocutaneous | 23 (95.8) | 26 (92.9) |
| Septocutaneous | 1 (4.2) | 2 (7.1) |
| Closure method (%) | ||
| Direct closure | 1 (4.2) | 14 (50.0) |
| Skin graft | SG: 23 (95.8) | SG: 14 (50.0) |
Values are presented as mean±SD (range) or number (%).
ALT, anterolateral thigh; VLM, vastus lateralis muscle; SD, standard deviation.
Fig. 2.Delayed healing and additional skin grafting
(A) Partial loss of grafted skin and fistula under the skin and proximal muscle extension were noted. (B) An incision was made just above the fistula 3 weeks after the initial operation. (C) An additional split-thickness meshed skin graft was applied on the subcutaneous tissue after debridement of the fistula.
Univariate and multivariate logistic regression analysis of risk factors associated with delayed healing at the free ALT flap donor site
| Variables | Univariate logistic regression | Multivariate logistic regression | ||||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | P-value | Odds ratio | 95% CI | P-value | |
| Age | 0.97 | 0.93–1.01 | 0.13 | - | - | - |
| Body mass index | 1.42 | 1.14–1.76 | 0.002[ | 1.35 | 1.00–1.80 | 0.044[ |
| Hypertension | 0.79 | 0.21–2.91 | 0.72 | - | - | - |
| Hyperlipidemia | 1.06 | 0.33–3.37 | 0.93 | - | - | - |
| Diabetes mellitus | 2.60 | 0.43–15.65 | 0.30 | - | - | - |
| Smoking | 5.87 | 1.69–20.36 | 0.005[ | 11.82 | 1.58–88.24 | 0.016[ |
| Hemoglobin | 1.40 | 1.01–1.93 | 0.043[ | 1.36 | 0.82–2.25 | 0.23 |
| Total protein | 0.89 | 0.39–2.05 | 0.79 | - | - | - |
| Albumin | 1.42 | 0.48–4.21 | 0.53 | - | - | - |
| Skin flap size | 1.01 | 0.99–1.01 | 0.062[ | 1.01 | 0.99–1.02 | 0.20 |
| VLM flap size | 1.01 | 0.99–1.03 | 0.23 | - | - | - |
| Multiple perforators | 1.62 | 0.54–4.85 | 0.39 | - | - | - |
| Musculocutaneous perforator | 1.77 | 0.15–20.82 | 0.65 | - | - | - |
| Skin graft | 23.00 | 2.72–194.47 | 0.004[ | 19.49 | 1.24–306.24 | 0.035[ |
ALT, anterolateral thigh; CI, confidence interval; VLM, vastus lateralis muscle.
P<0.1;
P<0.05.